BackStryker Overview
Stryker Corp.

Stryker Target Price

Where could SYK trade next? Consensus target price: $370.

Get informed when a big investor buys or sells

+ Follow

Share Price

$281.87

Average Target Price

$370.4231.4% upside

12 analysts in the last 4 months

High: $420 | Low: $317

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09BMO CapitalJoanne Wuensch$31712.5% upsideOpen
2026-09-09Wells FargoLarry Biegelsen$34823.5% upsideOpen
2026-07-31RBC CapitalShagun Singh$42049% upsideOpen
2026-07-31Raymond James$37031.3% upsideOpen
2026-07-31BTIGRyan Zimmerman$35827% upsideOpen
2026-07-31Piper Sandler$39038.4% upsideOpen
2026-07-31Wolfe Research$37533% upsideOpen
2026-07-13BTIG$37131.6% upsideOpen
2026-07-09Argus Research$37031.3% upsideOpen
2026-07-08BMO Capital$36930.9% upsideOpen
2026-07-06Evercore ISI$35024.2% upsideOpen
2026-06-05Leerink PartnersMike Kratky$40744.4% upsideOpen
2026-05-04Truist FinancialRichard Newitter$33017.1% upsideOpen
2026-05-04BarclaysMatt Miksic$39439.8% upsideOpen
2026-05-01Goldman SachsDavid Roman$36128.1% upsideOpen
2026-05-01Bernstein$41045.5% upsideOpen
2026-05-01Robert W. Baird$38536.6% upsideOpen
2026-05-01Evercore ISI$35525.9% upsideOpen
2026-05-01BTIG$37934.5% upsideOpen
2026-05-01Needham$41848.3% upsideOpen
2026-05-01Deutsche Bank$31511.8% upsideOpen
2026-03-04JefferiesMatthew Taylor$46565% upsideOpen
2026-02-24UBS$40041.9% upsideOpen
2026-02-02Barclays$46966.4% upsideOpen
2026-01-30NeedhamMike Matson$45461.1% upsideOpen
2026-01-30Robert W. Baird$43755% upsideOpen
2026-01-30BTIGRyan Zimmerman$41246.2% upsideOpen
2026-01-09BernsteinLee Hambright$46565% upsideOpen
2026-01-09Goldman Sachs$39941.6% upsideOpen
2026-01-06Raymond James$41848.3% upsideOpen
2026-01-05Evercore ISI$39038.4% upsideOpen
2025-11-14Truist FinancialRichard Newitter$40041.9% upsideOpen
2025-11-14RBC CapitalShagun Singh$43554.3% upsideOpen
2025-11-14NeedhamMike Matson$44858.9% upsideOpen
2025-11-03Truist Financial$39239.1% upsideOpen
2025-10-31Evercore ISI$40543.7% upsideOpen
2025-10-15Truist Financial$40744.4% upsideOpen
2025-10-13UBS$40844.7% upsideOpen
2025-10-07Evercore ISI$41045.5% upsideOpen
2025-09-18Redburn Partners$42049% upsideOpen
2025-08-04Truist Financial$41547.2% upsideOpen
2025-05-05BernsteinLee Hambright$45059.6% upsideOpen
2025-04-14BTIGRyan Zimmerman$40343% upsideOpen
2025-03-04Goldman Sachs$42249.7% upsideOpen
2025-02-03Argus ResearchDavid Toung$45059.6% upsideOpen
2024-12-18Truist FinancialRichard Newitter$40945.1% upsideOpen
2024-12-02Morgan StanleyPatrick Wood$44557.9% upsideOpen
2024-10-31CitigroupJoanne Wuensch$41145.8% upsideOpen
2024-10-30Piper SandlerMatt O'Brien$42049% upsideOpen
2024-10-30Truist FinancialRichard Newitter$38034.8% upsideOpen

Stryker (SYK) FAQ

As of the most recent data, SYK shows a target price of $370. Scroll down for historical charts and peer comparison views.

If Stryker moved to the average analyst target of $370, shares would be roughly 31.4% higher than $281.87. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Stryker's earnings trajectory.

Besides this target price page, Stockcircle has Stryker's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $370) with ownership activity and broader fundamentals.

Stryker's target price is $370; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.